Here again, no specific enrichment for a given subtype was identified, suggesting that the potential SMYD3–RNF113A methylation signaling may be relevant within the majority of SCLC (Fig. 3D; Supplementary Fig. S3C). Here, RNF113A is linked to small cell lung carcinoma.